Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Venetoclax

EU orphan designation number: EU/3/16/1766   
Active ingredient: Venetoclax
Indication: Treatment of diffuse large B-cell lymphoma
Sponsor: AbbVie Deutschland GmbH & Co. KG
Knollstrasse, 67061 Ludwigshafen, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/122/16 (2016)6758 of 14/10/2016
16/05/2018 Transfer of orphan designation EMA/OD/122/16/T/01 (2018)3026 of 8/05/2018